| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9955109 | Complementary Therapies in Medicine | 2018 | 16 Pages |
Abstract
Our study underpinned the safety and feasibility of high-dose mistletoe infusion in children with advanced stages of cancer and showed noteworthy antineoplastic effects, which should be verified in a prospective clinical phase II/III-study. Because of possible side effects, the treatment should be implemented only in an in-patient setting in experienced pediatric oncology centers.
Related Topics
Health Sciences
Medicine and Dentistry
Complementary and Alternative Medicine
Authors
Tycho Jan Zuzak, Anja Wasmuth, Stefan Bernitzki, Melanie Schwermer, Alfred Längler,